Our Partners

The Group comprises sound leading companies, mainly focused on health care, and quality of life optimization as well as on the supply of high technology services in strategic areas.

Fostering excellence, quality and self-improvement based on team work has been a priority. Based on this philosophy we devised a corporate structure with high levels of efficiency and management skills which helped us achieve a leading position in the international market.

We are proud of our permanent commitment to the strategic vision set out in 1934, and it is an honor to share with you the outcome of more than eight decades of hard work, based on enthusiasm and effort to be up to our challenge, and to compete in a world of scientific technology with worldwide quality and human passion.

Bagó’s origins go back to 1934, when Mr. Sebastián Bagó founded the pioneer company of the Group: Laboratorios Bagó. It was the first company to manufacture, in 1945, penicillin-based products in Argentina, one of the main scientific landmarks of this forerunner pharmaceutical company. Some years later, Bagó exported its medical products to other American and European countries.

Bagó Group´s current leading position in the Latin American market is based on a history of strong and continuous growth. Its renowned prestige stems from the joint effort of all and each of its employees, technicians and professionals, and its commitment to a unique goal: quality and excellence in health care.

At present, in a world of continuous and vertiginous changes, our Group still preserves and prioritizes the same values that have always distinguished us.

Excellence is the philosophy which drives the work of the 6.500 people comprising the Bagó Group and which inspires our initiatives and constant call for growth. By sharing these ideals we could achieve a sustained and on-going expansion, and go beyond borders to become one of the most important business groups devoted to health care.

The Bagó Group bulk chemical and pharmaceutical products are internationally renowned for their top quality and therapeutic effectiveness. Both quality and effectiveness are supported by the strictest pharmacotechnical and clinical evaluations, as well as by the most demanding international standards. Therefore, each one of our innovative products complies with the most advanced standards of treatment.

This policy has enabled us to expand the borders of our global activity. Today, Bagó is a synonym of excellence in over 47 countries of Latin America, Europe, Asia, Oceania and Africa where its products are sold; in 22 countries through direct presence (*) and in the rest of the markets through exports (**), thus ensuring patients and physicians a wide and varied range of state-of-the-art products.

(*) Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Ecuador, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Dominican Republic, Uruguay, Pakistan, Russia, Sri Lanka and Ukraine.

(**) Australia, Cameroon, China, South Korea, Côte d’Ivoire, Philippines, Kazakhstan, Japan, New Zealand, Singapore, Thailand and Vietnam, among others.

The Bagó Group is renowned for its unshakeable commitment to quality, the continuous therapeutic innovation of its products, the constant investment in R&D, the thrust, dynamics and effort of all the professionals working in the Group, and its competitive industrial structure.

The synergy of these factors together with the transparency of Bagó´s policy with respect to Intellectual Property Rights, have helped Bagó turn into a regional role model and strategic partner for the most important pharmaceutical companies worldwide. The strength of our leadership is shown by more than 25 in-licence products, and by a state-of-the-art line of products.

At present, the Bagó Group holds strategic commercial agreements and joint ventures with top class companies such as: Aspen, Astellas, Astra Zeneca, Boehringer Ingelheim, Ferrer, Ferozsons, Fidia, MSD, Novartis, Pfizer, Synthon and UCB, among others.